121 related articles for article (PubMed ID: 31241720)
1. Development and Initial Validation of Calculated Tumor Area as a Prognostic Tool in Cutaneous Malignant Melanoma.
Saldanha G; Yarrow J; Elsheikh S; O'Riordan M; Uraiby H; Bamford M
JAMA Dermatol; 2019 Aug; 155(8):890-898. PubMed ID: 31241720
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
3. The Width of Invasion in Malignant Melanoma Is a Novel Prognostic Feature That Accounts for Outcome Better Than Breslow Thickness.
Saldanha G; Khanna A; O'Riordan M; Bamford M
Am J Surg Pathol; 2020 Nov; 44(11):1522-1527. PubMed ID: 32604169
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
5. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
JAMA Dermatol; 2019 Sep; 155(9):1049-1056. PubMed ID: 31241717
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract][Full Text] [Related]
8. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
10. Breslow density is a novel prognostic feature in cutaneous malignant melanoma.
Rashed H; Flatman K; Bamford M; Teo KW; Saldanha G
Histopathology; 2017 Jan; 70(2):264-272. PubMed ID: 27502743
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.
Ma Q; Suo H; Zhu L; Qian Y; Sun X; Xie J; Li Q; Fu Y; Li J; Tao J
Cancer Med; 2020 Jul; 9(13):4561-4571. PubMed ID: 32367684
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
14. The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness).
El Sharouni MA; Rawson RV; Sigurdsson V; Witkamp AJ; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
J Am Acad Dermatol; 2022 Aug; 87(2):298-305. PubMed ID: 35121073
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma.
Kim E; Obermeyer I; Rubin N; Khariwala SS
Laryngoscope Investig Otolaryngol; 2021 Feb; 6(1):109-115. PubMed ID: 33614938
[TBL] [Abstract][Full Text] [Related]
16. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
17. Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study.
Hwa Lee S; Ung Ha G; Ji Lee H; Yun Chung H; Huh S; Ha DL; Duck Park K; Hyun Jang Y; Ju Lee W; Lee SJ; Young Kim J
Indian J Dermatol Venereol Leprol; 2023 May; ():1-7. PubMed ID: 37317716
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
19. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
[TBL] [Abstract][Full Text] [Related]
20. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]